Legal & General Group
IART icon

Legal & General Group’s Integra LifeSciences IART Stock Holding History

Legal & General Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.92M Sell
329,549
-67,375
-17% -$942K ﹤0.01% 1498
2026
Q1 		$3.74M Buy
396,924
+27,977
+8% +$307K ﹤0.01% 1646
2025
Q4 		$4.58M Buy
368,947
+126,215
+52% +$1.68M ﹤0.01% 1603
2025
Q3 		$3.48M Sell
242,732
-18,510
-7% -$254K ﹤0.01% 1745
2025
Q2 		$3.21M Buy
261,242
+45,825
+21% +$665K ﹤0.01% 1762
2025
Q1 		$4.74M Sell
215,417
-1,090
-0.5% -$25.6K ﹤0.01% 1553
2024
Q4 		$4.91M Sell
216,507
-10,277
-5% -$224K ﹤0.01% 1586
2024
Q3 		$4.12M Sell
226,784
-2,943
-1% -$68.2K ﹤0.01% 1662
2024
Q2 		$6.69M Buy
229,727
+43,193
+23% +$1.28M ﹤0.01% 1365
2024
Q1 		$6.61M Sell
186,534
-11,326
-6% -$453K ﹤0.01% 1370
2023
Q4 		$8.62M Sell
197,860
-19,706
-9% -$776K ﹤0.01% 1216
2023
Q3 		$8.31M Sell
217,566
-8,815
-4% -$371K ﹤0.01% 1164
2023
Q2 		$9.31M Buy
226,381
+18,836
+9% +$907K ﹤0.01% 1147
2023
Q1 		$11.9M Buy
207,545
+2,610
+1% +$147K ﹤0.01% 989
2022
Q4 		$11.5M Sell
204,935
-2,962
-1% -$151K ﹤0.01% 994
2022
Q3 		$8.81M Buy
207,897
+7,792
+4% +$399K ﹤0.01% 1091
2022
Q2 		$10.8M Sell
200,105
-3,236
-2% -$194K ﹤0.01% 1036
2022
Q1 		$13.1M Sell
203,341
-12,211
-6% -$804K ﹤0.01% 1044
2021
Q4 		$14.4M Buy
215,552
+5,007
+2% +$339K ﹤0.01% 1020
2021
Q3 		$14.4M Buy
210,545
+14,806
+8% +$1.05M ﹤0.01% 1008
2021
Q2 		$13.4M Sell
195,739
-18,966
-9% -$1.34M ﹤0.01% 1037
2021
Q1 		$14.8M Buy
214,705
+25,336
+13% +$1.72M 0.01% 991
2020
Q4 		$12.3M Sell
189,369
-1,750
-0.9% -$94.2K ﹤0.01% 1005
2020
Q3 		$9.03M Buy
191,119
+9,592
+5% +$456K ﹤0.01% 1053
2020
Q2 		$8.53M Buy
181,527
+76,295
+73% +$3.75M ﹤0.01% 1055
2020
Q1 		$4.75M Buy
105,232
+6,782
+7% +$356K ﹤0.01% 1180
2019
Q4 		$5.74M Buy
98,450
+7,010
+8% +$417K ﹤0.01% 1291
2019
Q3 		$5.49M Buy
91,440
+4,368
+5% +$260K ﹤0.01% 1259
2019
Q2 		$4.86M Buy
87,072
+5,281
+6% +$272K ﹤0.01% 1287
2019
Q1 		$4.56M Buy
81,791
+1,255
+2% +$63.9K ﹤0.01% 1240
2018
Q4 		$3.63M Buy
80,536
+3,661
+5% +$201K ﹤0.01% 1253
2018
Q3 		$5.06M Buy
76,875
+2,333
+3% +$145K ﹤0.01% 1166
2018
Q2 		$4.8M Sell
74,542
-59,620
-44% -$3.69M ﹤0.01% 1144
2018
Q1 		$7.4M Buy
134,162
+6,235
+5% +$327K 0.01% 920
2017
Q4 		$6.13M Buy
127,927
+2,721
+2% +$133K ﹤0.01% 980
2017
Q3 		$6.32M Buy
125,206
+8,399
+7% +$431K ﹤0.01% 922
2017
Q2 		$6.37M Buy
116,807
+10,775
+10% +$515K 0.01% 871
2017
Q1 		$4.47M Buy
106,032
+1,898
+2% +$81.1K ﹤0.01% 990
2016
Q4 		$4.47M Buy
104,134
+49,016
+89% +$1.99M ﹤0.01% 932
2016
Q3 		$2.27M Buy
55,118
+41,648
+309% +$1.74M ﹤0.01% 985
2016
Q2 		$531K Buy
13,470
+914
+7% +$32.9K ﹤0.01% 1326
2016
Q1 		$420K Buy
12,556
+2,358
+23% +$73.4K ﹤0.01% 1388
2015
Q4 		$346K Hold
10,198
– – ﹤0.01% 1484
2015
Q3 		$304K Sell
10,198
-2,277
-18% -$71.2K ﹤0.01% 1488
2015
Q2 		$344K Buy
12,475
+1,287
+12% +$34.3K ﹤0.01% 1479
2015
Q1 		$282K Buy
11,188
+2,368
+27% +$56K ﹤0.01% 1526
2014
Q4 		$198K Hold
8,820
– – ﹤0.01% 1578
2014
Q3 		$180K Buy
+8,820
New +$176K ﹤0.01% 1562

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Legal & General Group's IART Position: Q2 2026 in Review

Legal & General Group reduced its Integra LifeSciences (IART) stake by 17% in Q2 2026, selling an estimated $942K and leaving 329,549 shares worth $5.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Legal & General Group first reported a position in IART in Q3 2014 and has held it in 48 quarters since. The position peaked at $14.8M in Q1 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Legal & General Group held 329,549 shares of Integra LifeSciences worth $5.92M as of Q2 2026.
  • Legal & General Group sold 67,375 Integra LifeSciences shares in Q2 2026, an estimated $942K.
  • Integra LifeSciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #1498 holding.
  • Legal & General Group first reported a position in Integra LifeSciences in Q3 2014 and has held it in 48 quarters since.
  • Legal & General Group's Integra LifeSciences position peaked at $14.8M in Q1 2021.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.